eMedicine Specialties > Obstetrics and Gynecology > Gynecologic Surgery

Surgical Management of Abortion

Author: Natalie E Roche, MD, Department of Obstetrics, Gynecology and Women's Health, Assistant Professor, University of Medicine and Dentistry of New Jersey
Coauthor(s): Susanna J Park, MD, Department of Obstetrics, Gynecology and Women's Health, Assistant Professor, University of Medicine and Dentistry of New Jersey; Denise James, MD, Assistant Professor, Department of Obstetrics, Gynecology and Women's Health, University of Medicine and Dentistry of New Jersey
Contributor Information and Disclosures

Updated: Jun 16, 2006

Introduction

Abortion is the termination of pregnancy prior to viability of the fetus. Viability is the ability of the fetus to live independently from the mother and is defined as occurring at 24 weeks of gestation. Induced abortion can be elective (performed for nonmedical indications) or therapeutic (performed for medical indications). Abortion can be performed by surgical or medical means. This article is confined to a discussion of surgical methods of abortion.

History of the Procedure

All cultures have practiced abortion, and the practice of abortion has been documented as early as ancient times. Abortion is controversial and has been subject to an ongoing debate focused on 3 central questions: (1) When should abortion be allowed? (2) Who should make the decision about abortion, the individual or society? and (3) When does the fetus become human?

The answers to the 3 central questions have varied with time, place, and culture. In the United States, the modern debate about abortion began in the 1820s with antiabortion legislation targeted against high maternal mortality rates associated with abortion. Notable in the 20th century was Roe v Wade, the 1973 Supreme Court ruling that guaranteed the fundamental right of a woman to decide whether to terminate her pregnancy. The 1973 Supreme Court ruling did not end the controversy surrounding abortion, and it continues today with legislation and legal intervention at the state and federal levels.

Problem

Abortion is one of the most common surgical procedures performed for American women. Based on estimated lifetime risk, each American woman is expected to have 3.2 pregnancies, of which 2 will be a live birth, 0.7 will be an induced abortion, and 0.5 will be a miscarriage. Using 1996 data, this translates into 3.89 million live births, 1.37 million abortions, and 0.98 million miscarriages.

Frequency

The Centers for Disease Control and Prevention (CDC) data are based upon information on legally induced abortions voluntarily submitted by states and by 2 areas of occurrence (ie, District of Columbia, New York City). The most current figures were compiled in 2001; this information does not include statistics from the states of Alaska, California, or New Hampshire.

The Alan Guttmacher Institute (AGI) is a private organization that is not subject to the reporting limitations of state health departments. AGI contacts abortion providers directly and provides abortion data every 4-5 years. A previous report documented a discrepancy of approximately 12% between statistical figures presented by the CDC compared with those of AGI (the latter generally having higher estimates). CDC figures were used for this article.

A total of 853,485 legal induced abortions were reported to the CDC for 2001 from the 49 reporting areas. This reflects a decline of 0.5% from the number of legal induced abortions reported for 2000 from the same reporting areas.

The abortion rate in the United States has steadily declined from a peak of 29.4 per 1000 women aged 15-44 years in 1990 to a low of 16 per 1000 women in 2001. The decline in the abortion rate has been attributed to a decrease in the number of unintended pregnancies, increased use of condoms and long-acting hormonal contraceptives in young women, reduced or limited access to abortion services, including the passage of abortion laws that affect adolescents (eg, parental consent, notification laws and mandatory waiting periods), and a shift in the age distribution of women toward the older and less fertile ages.

The abortion rates reported for the United States were higher than those reported for Canada and Western European countries but lower than the rates reported for China, Cuba, most of Eastern European countries, and certain newly independent states of the former Soviet Union.

Most abortions in the United States were performed in the first trimester: 59% of abortions were performed at less than 8 weeks' gestation and 88% of abortions were performed at less than 13 weeks' gestation. Few abortions were performed in the second trimester: 4.3% at 16-20 weeks and 1.4% at more than 21 weeks. In 2000 (the most recent year for which data are available), as in previous years, deaths related to legally induced abortions occurred rarely at less than one death per 100,000 abortions, making surgical abortion one of the safest surgical procedures performed in the United States.

The trend over the last reported years (1992-1997) has been toward abortions performed earlier in gestation. From 1992 (when detailed data on early abortions were first available) through 2001, data have indicated steady increases in procedures performed at less than 6 weeks' gestation with decreases occurring in the percentage of abortions performed at 8-12 weeks' gestation. The proportion of abortions performed at more than 13 weeks has varied little since 1992. Abortions performed early in pregnancy are associated with lower risks of mortality and morbidity. Early surgical abortions ( <6 wk) has been shown to be safe and effective with complication rates comparable with that of mifepristone and vaginal misoprostol.

For the abortions reported in the United States, the vast majority are performed using surgical methods. For women whose type of procedure was adequately reported, 95% of abortions were performed by curettage (which includes dilatation and evacuation [D&E]) and 0.5% were performed by intrauterine instillation. The percentage of abortions performed by D&E (curettage) at more than 13 weeks' gestation increased from 31% in 1974 (the first year for which these data were available) to 96% in 2001, while the percentage of abortions performed by intrauterine instillation at more than 13 weeks' gestation decreased from 57% to 0.5%. The increase in D&E (and the associated decrease in intrauterine instillation) is likely attributable to the lower risk of complications associated with D&E. Hysterotomy and hysterectomy were used in less than 0.01% of all abortions.

Etiology

Abortion is by definition a reproductive failure. The failure can be the result of the mother's lack of access to care, failure of the contraceptive method, failure to use contraceptives, or failure of the normal reproductive process (eg, fetal anomalies, fetal death, maternal illness).

Data from 1987 documented that 50% of all pregnancies in the United States were unintended. The large number of unintended pregnancies accounts for the bulk of pregnancy terminations in the United States.

Presentation

The decision to end a pregnancy may be made prior to the diagnosis of pregnancy. Many women present for pregnancy diagnosis with a simultaneous request for abortion. Women should be encouraged to have early diagnosis of pregnancy for the following reasons:

  • The earlier the diagnosis of pregnancy, the greater the number of abortion methods available.
  • Earlier diagnosis of pregnancy allows a greater chance for early abortion and lower complication rates.
  • Earlier diagnosis of pregnancy allows earlier diagnosis of possible ectopic pregnancy and lower complication rates.
  • Earlier diagnosis of pregnancy enables earlier entry into prenatal care and earlier diagnosis of indications for therapeutic abortion.

Obtain medical, surgical, and obstetric/gynecological history to help differentiate healthy pregnancies from abnormal pregnancies. Symptoms of normal pregnancy include anorexia, nausea, vomiting, breast tenderness, amenorrhea, and lethargy. Symptoms of abnormal pregnancy include abdominal pain, vaginal bleeding, passage of tissue, and near syncope or syncope.

Most elective abortions are performed in women aged 20-24 years. Most therapeutic abortions are performed in women older than 35 years. The most likely profile of patient requesting an elective abortion is that of an unmarried white woman who is younger than 25 years. Females younger than 15 years comprise fewer than 1% of all abortion patients.

Many patients who present with an abortion request are upset and frightened. Adequate counseling with discussion of all options available for the pregnancy and explanation of abortion options, risks, and complications is mandatory.

Indications

Elective abortion is the termination of pregnancy for nonmedical indications as determined by the patient.

Therapeutic abortion is termination of pregnancy for medical indications, including the following:

  • Medical illness in the mother in which continuation of the pregnancy has the potential to threaten the life or health of the mother: Consider the present medical condition and a reasonable prediction of future circumstances because few medical indications are absolute.
  • Rape or incest
  • Fetal anomalies when pregnancy outcome is likely to be birth of a child with significant mental or physical defects or high likelihood of intrauterine or neonatal death
  • Fetal death

Relevant Anatomy

Adequate evaluation of uterine size is mandatory. Physical examination may be inadequate for uterine sizing. Common causes of inadequate sizing by physical examination are obesity, uterine fibroids, patient apprehension with voluntary guarding, retroverted uterus, and firm abdominal musculature in young patients.

  • Obtaining ultrasound confirmation of gestational age prior to abortion in the second trimester is common practice.
  • A small or stenotic cervical os may prevent adequate dilatation for a surgical abortion.
  • Uterine leiomyoma may make uterine sizing by physical examination erroneous, dilatation of the cervix difficult or impossible, and introduction of suction tips and curets into the uterine cavity difficult or impossible. Ultrasound prior to abortion is recommended, and ultrasound guidance during the abortion procedure may be helpful.
  • Previous uterine surgery may increase the risk of perforation during surgical abortion.
  • Previous uterine surgery and high parity are associated with greater likelihood of placenta praevia, placenta accreta, and placenta percreta. Surgical abortion should be performed in a setting where blood transfusion and access to laparotomy are available.
  • Scarring of the cervix caused by cone biopsy or delivery may increase the risk of cervical stenosis and damage to cervix at dilatation. Consider passive dilatation with osmotic dilators (eg, laminaria, Dilapan).
  • Uterine anomalies (eg, uterine septum, double uterus) may make entry into and emptying of the uterus complicated. Ultrasound guidance during abortion procedures is recommended.
  • Multiple gestations may make surgical abortion more technically challenging. Adequate cervical dilatation and equipment appropriate to uterine size (not dates) is recommended.
  • For an adnexal mass, the physician must obtain an ultrasound to exclude ectopic pregnancy and to determine the nature of the mass.
  • Selection of the surgical abortion procedure primarily depends on the gestational age of the pregnancy.
  • Careful consideration of choice of anesthesia must be based on the medical, psychiatric, and emotional condition of the patient. Local anesthesia affords greatest safety. General anesthesia is associated with greater risk of anesthesia complications and hemorrhage.

Contraindications

Absolute contraindications are virtually unknown. If abortion presents a medical risk to the patient, then continuation of the pregnancy presents an even greater risk. The type and timing of an abortion procedure or method may be contraindicated based on the medical, surgical, or psychiatric condition of the patient.

  • Medical abortion is contraindicated in patients with clotting disorders, severe liver disease, renal disease, cardiac disease, and chronic steroid use.
  • Surgical abortion is contraindicated in patients with hemodynamic instability, profound anemia, and/or profound thrombocytopenia.
  • The rare instance of placenta accreta and percreta in the second trimester may necessitate laparotomy with hysterotomy or hysterectomy.

More on Surgical Management of Abortion

Overview: Surgical Management of Abortion
Workup: Surgical Management of Abortion
Treatment: Surgical Management of Abortion
Follow-up: Surgical Management of Abortion
References

References

  1. American College of Obstetricians and Gynecologists. Methods of Midtrimester Abortion. ACOG Technical Bulletin. 1987;1-4.

  2. American College of Obstetricians and Gynecologists. Abortion Policy. ACOG Compendium of Selected Publications. 2005; 865-867.

  3. Borgatta L, Chen AY, Reid SK. Pelvic embolization for treatment of hemorrhage related to spontaneous and induced abortion. Am J Obstet Gynecol. Sep 2001;185(3):530-6. [Medline].

  4. Borgmann CE, Jones BS. Legal issues in the provision of medical abortion. Am J Obstet Gynecol. Aug 2000;183(2 Suppl):S84-94. [Medline].

  5. Castadot RG. Pregnancy termination: techniques, risks, and complications and their management. Fertil Steril. Jan 1986;45(1):5-17. [Medline].

  6. Cates W, Ellertson C. Abortion. In: Hatcher RA, Trussel J, Stewart F, et al. Contraceptive Technology. 17th ed. New York, NY:. Ardent Media;1998:682-697.

  7. Chapman SJ, Crispens M, Owen J. Complications of midtrimester pregnancy termination: the effect of prior cesarean delivery. Am J Obstet Gynecol. Oct 1996;175(4 Pt 1):889-92. [Medline].

  8. Chasen ST, Kalish RB, Gupta M. Dilation and evacuation at >or=20 weeks: comparison of operative techniques. Am J Obstet Gynecol. May 2004;190(5):1180-3. [Medline].

  9. Daling JR, Emanuel I. Induced abortion and subsequent outcome of pregnancy. A matched cohort study. Lancet. Jul 26 1975;2(7926):170-3. [Medline].

  10. Dean G, Cardenas L, Darney P. Acceptability of manual versus electric aspiration for first trimester abortion: a randomized trial. Contraception. Mar 2003;67(3):201-6. [Medline].

  11. Frank PI, McNamee R, Hannaford PC. The effect of induced abortion on subsequent pregnancy outcome. Br J Obstet Gynaecol. Oct 1991;98(10):1015-24. [Medline].

  12. Grimes DA, Schulz KF. Morbidity and mortality from second-trimester abortions. J Reprod Med. Jul 1985;30(7):505-14. [Medline].

  13. Grimes DA. Unsafe abortion: the silent scourge. Br Med Bull. 2003;67:99-113.

  14. Hakim-Elahi E, Tovell HM, Burnhill MS. Complications of first-trimester abortion: a report of 170,000 cases. Obstet Gynecol. Jul 1990;76(1):129-35. [Medline].

  15. Hamoda H, Ashok PW, Flett GM. A randomised controlled trial of mifepristone in combination with misoprostol administered sublingually or vaginally for medical abortion up to 13 weeks of gestation. BJOG. Aug 2005;112(8):1102-8.

  16. Heath V, Chadwick V, Cooke I, et al. Should tissue from pregnancy termination and uterine evacuation routinely be examined histologically?. BJOG. Jun 2000;107(6):727-30. [Medline].

  17. Hern WM. Second-trimester surgical abortions. In: Sciarra JJ. Gynecology and Obstetrics. Philadelphia, PA:JB Lippincott Co; 2002.

  18. Jackson RA, Teplin VL, Drey EA. Digoxin to facilitate late second-trimester abortion: a randomized, masked, placebo-controlled trial. Obstet Gynecol. Mar 2001;97(3):471-6. [Medline].

  19. Kalish RB, Chasen ST, Rosenzweig LB. Impact of midtrimester dilation and evacuation on subsequent pregnancy outcome. Am J Obstet Gynecol. Oct 2002;187(4):882-5. [Medline].

  20. Keder LM. Best practices in surgical abortion. Am J Obstet Gynecol. Aug 2003;189(2):418-22. [Medline].

  21. Kero A. Wellbeing and mental growth - long term effects of legal abortion.

  22. Kero A, Högberg U, Lalos A. Wellbeing and mental growth-long-term effects of legal abortion. Soc Sci Med. Jun 2004;58(12):2559-69.

  23. Linn S, Schoenbaum SC, Monson RR. The relationship between induced abortion and outcome of subsequent pregnancies. Am J Obstet Gynecol. May 15 1983;146(2):136-40. [Medline].

  24. Lähteenmäki P, Luukkainen T. Return of ovarian function after abortion. Clin Endocrinol (Oxf). Feb 1978;8(2):123-32. [Medline].

  25. MacIsaac L, Grossman D, Balistreri E, Darney P. A randomized controlled trial of laminaria, oral misoprostol, and vaginal misoprostol before abortion. Obstet Gynecol. May 1999;93(5 Pt 1):766-70. [Medline].

  26. Macisaac L, Darney P. Early surgical abortion: an alternative to and backup for medical abortion. Am J Obstet Gynecol. Aug 2000;183(2 Suppl):S76-83. [Medline].

  27. Pakarinen P, Toivonen J, Luukkainen T. Randomized comparison of levonorgestrel- and copper-releasing intrauterine systems immediately after abortion, with 5 years'' follow-up. Contraception. Jul 2003;68(1):31-4. [Medline].

  28. Paul M. Office management of early induced abortion. Clin Obstet Gynecol. Jun 1999;42(2):290-305. [Medline].

  29. Paul ME, Mitchell CM, Rogers AJ. Early surgical abortion: efficacy and safety. Am J Obstet Gynecol. Aug 2002;187(2):407-11. [Medline].

  30. Penfield AJ. Gynecologic Surgery Under Local Anesthesia. Baltimore, Md:. Urban & Schwarzenburg;1986: 65-94.

  31. Pope LM, Adler NE, Tschann JM. Postabortion psychological adjustment: are minors at increased risk?. J Adolesc Health. Jul 2001;29(1):2-11. [Medline].

  32. Pridmore BR, Chambers DG. Uterine perforation during surgical abortion: a review of diagnosis, management and prevention. Aust N Z J Obstet Gynaecol. Aug 1999;39(3):349-53. [Medline].

  33. Sawaya GF, Grady D, Kerlikowske K, Grimes DA. Antibiotics at the time of induced abortion: the case for universal prophylaxis based on a meta-analysis. Obstet Gynecol. May 1996;87(5 Pt 2):884-90. [Medline].

  34. Stotland NL. The myth of the abortion trauma syndrome. JAMA. Oct 21 1992;268(15):2078-9. [Medline].

  35. Strauss LT, Herndon J, Chang J, et al. Abortion surveillance--United States, 2001. MMWR Surveill Summ. Nov 26 2004;53(9):1-32.

  36. Ventura SJ, Mosher WD, Curtin SC. Trends in pregnancies and pregnancy rates by outcome: estimates for the United States, 1976-96. Vital Health Stat 21. Jan 2000;(56):1-47. [Medline].

Further Reading

Keywords

surgical management of abortion, termination of pregnancy, TOP, menstrual extraction, manual vacuum aspiration, suction curettage, dilation and extraction, dilation and evacuation, dilatation and evacuation, D&E, hysterotomy, laparotomy, hysterectomy, products of conception, POC, Roe v Wade

Contributor Information and Disclosures

Author

Natalie E Roche, MD, Department of Obstetrics, Gynecology and Women's Health, Assistant Professor, University of Medicine and Dentistry of New Jersey
Natalie E Roche, MD is a member of the following medical societies: American College of Obstetricians and Gynecologists, American Medical Association, Association of Professors of Gynecology and Obstetrics, Association of Reproductive Health Professionals, International AIDS Society, National Medical Association, and New York Academy of Sciences
Disclosure: Nothing to disclose.

Coauthor(s)

Susanna J Park, MD, Department of Obstetrics, Gynecology and Women's Health, Assistant Professor, University of Medicine and Dentistry of New Jersey
Susanna J Park, MD is a member of the following medical societies: American College of Obstetricians and Gynecologists
Disclosure: Nothing to disclose.

Denise James, MD, Assistant Professor, Department of Obstetrics, Gynecology and Women's Health, University of Medicine and Dentistry of New Jersey
Disclosure: Nothing to disclose.

Pharmacy Editor

Francisco Talavera, PharmD, PhD, Senior Pharmacy Editor, eMedicine
Disclosure: Nothing to disclose.

CME Editor

Frederick B Gaupp, MD, Consulting Staff, Department of Family Practice, Assumption Community Hospital
Frederick B Gaupp, MD is a member of the following medical societies: American Academy of Family Physicians
Disclosure: Nothing to disclose.

Chief Editor

Lee P Shulman, MD, Professor of Obstetrics and Gynecology, Feinberg School of Medicine, Northwestern University; Chief, Division of Reproductive Genetics, Department of Obstetrics and Gynecology, Prentice Women's Hospital, Northwestern Memorial Hospital
Lee P Shulman, MD is a member of the following medical societies: American College of Medical Genetics, American College of Obstetricians and Gynecologists, American Medical Association, American Society for Reproductive Medicine, American Society of Human Genetics, Association of Reproductive Health Professionals, Central Association of Obstetricians and Gynecologists, Chicago Medical Society, Illinois State Medical Society, North American Society for Pediatric and Adolescent Gynecology, Phi Beta Kappa, Society for Gynecologic Investigation, Society for Maternal-Fetal Medicine, and Tennessee Medical Association
Disclosure: Nothing to disclose.

RELATED EMEDICINE ARTICLES
 
 
HONcode

We subscribe to the
HONcode principles of the
Health On the Net Foundation

All material on this website is protected by copyright, Copyright© 1994- by Medscape.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.